Cited by

• Fluconazole monotherapy for cryptococcosis in non-AIDS patients.

  Yamaguchi H, Ikemoto H, Watanabe K, Ito A, Hara K, Kohno S. Yamaguchi H, et al. Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):787-92. doi: 10.1007/BF01701520. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8950555
• Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.

  Behre GF, Schwartz S, Lenz K, Ludwig WD, Wandt H, Schilling E, Heinemann V, Link H, Trittin A, Boenisch O, et al. Behre GF, et al. Ann Hematol. 1995 Dec;71(6):287-91. doi: 10.1007/BF01697981. Ann Hematol. 1995. PMID: 8534760 Clinical Trial.
• Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.

  Pfaller MA, Bale M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex JH, Rinaldi MG. Pfaller MA, et al. J Clin Microbiol. 1994 Jul;32(7):1650-3. doi: 10.1128/jcm.32.7.1650-1653.1994. J Clin Microbiol. 1994. PMID: 7929752 Free PMC article.
• Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study.

  Egger T, Gratwohl A, Tichelli A, Uhr M, Stebler Gysi C, Passweg J, Pless M, Wernli M, Buser U, Wuhrmann J, et al. Egger T, et al. Support Care Cancer. 1995 Mar;3(2):139-46. doi: 10.1007/BF00365855. Support Care Cancer. 1995. PMID: 7773582 Clinical Trial.
• Persistent pulmonary lesion in a patient with rheumatoid arthritis.

  Buttgereit F, Künzel K, Tietz HJ, Sajkiewicz K, Gellert K, Hiepe F, Burmester GR. Buttgereit F, et al. Ann Rheum Dis. 1994 Dec;53(12):798-800. doi: 10.1136/ard.53.12.798. Ann Rheum Dis. 1994. PMID: 7864686 Free PMC article. No abstract available.